home / stock / gntlf / gntlf news

GNTLF News and Press, Genetic Techs Ltd Aud From 02/27/23

Stock Information
Company Name: Genetic Techs Ltd Aud
Stock Symbol: GNTLF
Market: OTC
Website: gtglabs.com
Menu
GNTLF GNTLF Quote GNTLF Short GNTLF News GNTLF Articles GNTLF Message Board
Get GNTLF Alerts

News, Short Squeeze, Breakout and More Instantly...
GNTLF - Genetic Technologies Limited (GENE) Q2 2023 Earnings Call Transcript

Genetic Technologies Limited (GENE) Q2 2023 Earnings Conference Call Feb 27, 2023, 05:00 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - CEO Tony Di Pietro – CFO Carl Stubbings - Chief Commercial Officer Conference Call P...
GNTLF - New Publication Highlights geneType's Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification

MELBOURNE, Australia, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce the publication of a...

GNTLF - Genetic Technologies Announces Closing of $5 Million Registered Direct Offering

MELBOURNE, Australia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, to...

GNTLF - Genetic Technologies to Launch Ground-breaking Comprehensive Risk Test for Breast & Ovarian Cancer

MELBOURNE, Australia, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is delighted to provide further update. The innovation ...
GNTLF - Genetic Technologies Announces $5 Million Registered Direct Offering

MELBOURNE, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, to...

GNTLF - GENE to Launch World's First Comprehensive Risk Test for Breast & Ovarian Cancer

MELBOURNE, Australia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company will launch a ‘Wor...

GNTLF - GTG to form Strategic Alliance with global testing leader QIAGEN

MELBOURNE, Australia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to announce that the Company is ...
GNTLF - Quarterly Business Update - December 2022; Sixth Consecutive Quarter of Growth

MELBOURNE, Australia, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,” Company”, “GTG”), a global leader in guidance-driven genomics-based tests in health, wellness and serious diseases releases its Quarterly business update for th...

GNTLF - Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium

MELBOURNE, Australia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease – is pleased to announce a poster presentatio...

GNTLF - Genetic Technologies Provides Business Update

MELBOURNE, Australia, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE,”Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, is pleased to provide the following business...
Previous 10 Next 10